Huntington's disease: clinical presentation and treatment
- PMID: 21907093
- DOI: 10.1016/B978-0-12-381328-2.00013-4
Huntington's disease: clinical presentation and treatment
Abstract
Huntington's disease (HD) is a devastating inherited neurodegenerative disease characterized primarily by progressive motor, cognitive, and psychiatric symptoms. It is caused by autosomal dominant inheritance of an expanded CAG repeat within the Huntington's gene on chromosome 4. In this chapter, we characterize the typical and variant motor phenotypes of the disease and then proceed to describe the cognitive and psychiatric profile. We then give an overview of a suggested multidisciplinary approach to the management of HD, emphasizing the fact that it is a disease which impacts on entire families rather than affecting individuals in isolation. We then describe the pharmacological and nonpharmacological options available for management of specific symptoms.
Copyright © 2011 Elsevier Inc. All rights reserved.
Similar articles
-
Autopsy-proven Huntington's disease with 29 trinucleotide repeats.Mov Disord. 2007 Jan;22(1):127-30. doi: 10.1002/mds.21195. Mov Disord. 2007. PMID: 17115386
-
Genetics and neuropathology of Huntington's disease.Int Rev Neurobiol. 2011;98:325-72. doi: 10.1016/B978-0-12-381328-2.00014-6. Int Rev Neurobiol. 2011. PMID: 21907094 Free PMC article. Review.
-
Huntington's disease - clinical signs, symptoms, presymptomatic diagnosis, and diagnosis.Handb Clin Neurol. 2011;100:3-13. doi: 10.1016/B978-0-444-52014-2.00001-X. Handb Clin Neurol. 2011. PMID: 21496568 Review.
-
Immunomodulatory Strategies for Huntington's Disease Treatment.CNS Neurol Disord Drug Targets. 2017;16(8):936-944. doi: 10.2174/1871527316666170613084801. CNS Neurol Disord Drug Targets. 2017. PMID: 28606048 Review.
-
Huntington's Disease: Relationship Between Phenotype and Genotype.Mol Neurobiol. 2017 Jan;54(1):342-348. doi: 10.1007/s12035-015-9662-8. Epub 2016 Jan 7. Mol Neurobiol. 2017. PMID: 26742514 Review.
Cited by
-
The differential diagnosis of Huntington's disease-like syndromes: 'red flags' for the clinician.J Neurol Neurosurg Psychiatry. 2013 Jun;84(6):650-6. doi: 10.1136/jnnp-2012-302532. Epub 2012 Sep 19. J Neurol Neurosurg Psychiatry. 2013. PMID: 22993450 Free PMC article.
-
Spatiotemporal Gait Parameters in Adults With Premanifest and Manifest Huntington's Disease: A Systematic Review.J Mov Disord. 2023 Sep;16(3):307-320. doi: 10.14802/jmd.23111. Epub 2023 Aug 10. J Mov Disord. 2023. PMID: 37558234 Free PMC article.
-
Unmet needs for healthcare and social support services in patients with Huntington's disease: a cross-sectional population-based study.Orphanet J Rare Dis. 2015 Sep 28;10:124. doi: 10.1186/s13023-015-0324-8. Orphanet J Rare Dis. 2015. PMID: 26411462 Free PMC article.
-
Defective Sphingosine-1-phosphate metabolism is a druggable target in Huntington's disease.Sci Rep. 2017 Jul 13;7(1):5280. doi: 10.1038/s41598-017-05709-y. Sci Rep. 2017. PMID: 28706199 Free PMC article.
-
Detailed Analysis of the Palmomental Reflex and Its Clinical Significance.Brain Behav. 2024 Nov;14(11):e70164. doi: 10.1002/brb3.70164. Brain Behav. 2024. PMID: 39576271 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical